Imipramine
- Generic Name
- Imipramine
- Brand Names
- Tofranil
- Drug Type
- Small Molecule
- Chemical Formula
- C19H24N2
- CAS Number
- 50-49-7
- Unique Ingredient Identifier
- OGG85SX4E4
- Background
Imipramine, the prototypical tricyclic antidepressant (TCA), is a dibenzazepine-derivative TCA. TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, imipramine does not affect mood or arousal, but may cause sedation. In depressed individuals, i...
- Indication
For the relief of symptoms of depression and as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older .
...
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Bulimia Nervosa, Depression, Enuresis, Neuropathic Pain, Panic Disorder
- Associated Therapies
- -
Cardiac Arrhythmia Pilot Study (CAPS)
Phase 2
Completed
- Conditions
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
Phase 3
Completed
- Conditions
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2013-07-29
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00000464
Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2016-01-21
- Lead Sponsor
- University of Utah
- Registration Number
- NCT00000518
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath